Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-049938)

Filing Details

Accession Number:: 0001209191-22-049938
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-09-14 16:58:34
Reporting Period:: 2022-09-12

Accepted Time:: 2022-09-14 16:58:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636651	Ovid Therapeutics Inc.	OVID	Pharmaceutical Preparations (2834)	465270895

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1794698	Jason Tardio	C/O Ovid Therapeutics Inc. 1460 Broadway, Suite 15044 New York NY 10036	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-09-12	17,344	$2.15	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The Reporting Person acquired the shares pursuant to the Issuer's employee stock purchase plan. These transactions were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Following the reported transaction, the Reporting Person will hold no ESPP shares.